Tissue Engineering (Heart Valves)
Tissue-engineered valve is a living organ, able to respond to growth and physiological forces in the same way that the native aortic valve does. It can overcome the deficiencies of mechanical and animal valves (lifelong anticoagulation and immunosuppressant therapy) which are currently in clinical use.
Themarket share of Biological valves is a meagre 23% in India
(2012 data) With advancements in Tissue Engineering,this
is set to increase drastically. We are targetingfor 10 % share of
mechanical valves.
